T.S. Ravikumar

2.2k total citations
49 papers, 1.7k citations indexed

About

T.S. Ravikumar is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, T.S. Ravikumar has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 14 papers in Hepatology. Recurrent topics in T.S. Ravikumar's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Liver Disease Diagnosis and Treatment (4 papers). T.S. Ravikumar is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Liver Disease Diagnosis and Treatment (4 papers). T.S. Ravikumar collaborates with scholars based in United States, India and United Kingdom. T.S. Ravikumar's co-authors include Glenn Steele, Weng‐Lang Yang, Haiyun Deng, G Steele, Robert A. Kane, Weng-Lang Yang, Deepak G. Nair, Wancai Yang, Huali Dong and Peter N. Benotti and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

T.S. Ravikumar

45 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.S. Ravikumar United States 19 822 767 431 366 277 49 1.7k
Carlo Paties Italy 20 660 0.8× 637 0.8× 360 0.8× 291 0.8× 626 2.3× 51 2.0k
Masaaki Kondo Japan 24 733 0.9× 318 0.4× 434 1.0× 328 0.9× 237 0.9× 91 1.6k
Thomas F. Wood United States 14 548 0.7× 664 0.9× 520 1.2× 98 0.3× 267 1.0× 23 1.4k
Alexander Chung Singapore 15 752 0.9× 565 0.7× 438 1.0× 323 0.9× 346 1.2× 34 1.8k
Pramod Rao France 27 780 0.9× 381 0.5× 755 1.8× 293 0.8× 656 2.4× 66 2.1k
Michiaki Matsushita Japan 28 1.1k 1.4× 361 0.5× 1.2k 2.9× 198 0.5× 505 1.8× 105 2.4k
Zhiyu Han China 22 727 0.9× 318 0.4× 734 1.7× 177 0.5× 458 1.7× 122 1.8k
F. Cremona Italy 12 838 1.0× 349 0.5× 388 0.9× 88 0.2× 277 1.0× 21 1.3k
Adriana Handra‐Luca France 16 940 1.1× 447 0.6× 525 1.2× 264 0.7× 180 0.6× 62 2.0k

Countries citing papers authored by T.S. Ravikumar

Since Specialization
Citations

This map shows the geographic impact of T.S. Ravikumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.S. Ravikumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.S. Ravikumar more than expected).

Fields of papers citing papers by T.S. Ravikumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.S. Ravikumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.S. Ravikumar. The network helps show where T.S. Ravikumar may publish in the future.

Co-authorship network of co-authors of T.S. Ravikumar

This figure shows the co-authorship network connecting the top 25 collaborators of T.S. Ravikumar. A scholar is included among the top collaborators of T.S. Ravikumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.S. Ravikumar. T.S. Ravikumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vairappan, Balasubramaniyan, et al.. (2024). Nimbolide attenuates hepatocellular carcinoma by regulating miRNAs 21, 145 and 221 and their target gene expression. Gene. 937. 149126–149126. 1 indexed citations
2.
Vairappan, Balasubramaniyan, et al.. (2023). Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF. European Journal of Pharmacology. 958. 176010–176010. 5 indexed citations
3.
Ravikumar, T.S., et al.. (2021). Role of high dose oral liposomal vitamin -C in reducing mortality in patients with COVID-19. 10(3). 96–104. 4 indexed citations
5.
Ravikumar, T.S., et al.. (2019). Cardiac Autonomic Neuropathy- An ECG Correlation in Type 2 Diabetes. Journal of Evolution of Medical and Dental Sciences. 8(35). 2733–2737.
6.
Deng, Haiyun, T.S. Ravikumar, & Weng‐Lang Yang. (2009). Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Letters. 281(2). 220–231. 44 indexed citations
7.
Deng, Haiyun, et al.. (2007). Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Experimental Cell Research. 313(5). 1033–1044. 108 indexed citations
8.
Deng, Haiyun, T.S. Ravikumar, & Weng‐Lang Yang. (2007). Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells. Cancer Letters. 256(2). 207–217. 30 indexed citations
9.
Yang, Weng-Lang, et al.. (2004). Heat Shock Protein 70 Is Induced in Mouse Human Colon Tumor Xenografts After Sublethal Radiofrequency Ablation. Annals of Surgical Oncology. 11(4). 399–406. 51 indexed citations
10.
Yang, Weng‐Lang, et al.. (2001). Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: Mediation by cytochrome c release. International Journal of Cancer. 93(4). 526–533. 64 indexed citations
11.
Goodin, Susan, et al.. (1997). Chemotherapy for Metastatic Melanoma during Pregnancy. Gynecologic Oncology. 66(3). 526–530. 42 indexed citations
12.
Ravikumar, T.S., G Pizzorno, John C. Marsh, et al.. (1994). Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.. Journal of Clinical Oncology. 12(12). 2723–2736. 58 indexed citations
13.
Glickman, Morton G., et al.. (1992). Percutaneous Isolated Liver Perfusion for Treatment of Hepatic Malignancy: Preliminary Report. Journal of Vascular and Interventional Radiology. 3(3). 453–458. 28 indexed citations
14.
Saini, Kulvinder Singh, et al.. (1992). Differences in Messenger RNA Expression of Carcinoembryonic Antigen in Surgical Specimens of Colorectal Carcinoma. Tumor Biology. 13(5-6). 330–337. 11 indexed citations
15.
Ravikumar, T.S.. (1991). A 5-Year Study of Cryosurgery in the Treatment of Liver Tumors. Archives of Surgery. 126(12). 1520–1520. 201 indexed citations
16.
Ravikumar, T.S., Catharina Olsen, & Glenn Steele. (1990). Resection of pulmonary and hepatic metastasis in the management of cancer. Critical Reviews in Oncology/Hematology. 10(2). 111–130. 2 indexed citations
17.
Steele, Glenn, T.S. Ravikumar, & Peter N. Benotti. (1990). New surgical treatments for recurrent colorectal cancer. Cancer. 65(S3). 723–730. 46 indexed citations
18.
Ravikumar, T.S., et al.. (1990). Clinical evaluation of a side entry access port: a novel dual-lumen venous access device.. Journal of Clinical Oncology. 8(11). 1880–1884. 3 indexed citations
19.
Ravikumar, T.S.. (1989). Experimental Liver Metastasis. Archives of Surgery. 124(1). 49–49. 21 indexed citations
20.
Steele, Glenn & T.S. Ravikumar. (1989). Resection of Hepatic Metastases from Colorectal Cancer Biologic Perspectives. Annals of Surgery. 210(2). 127–138. 428 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026